Laboratory Tests for Suspected Lead Exposure
Blood lead level (BLL) testing is the primary laboratory test indicated for suspected lead exposure, with venous blood samples being the preferred specimen type over capillary samples for confirmatory testing. 1
Primary Testing Method
Blood Lead Level (BLL) Testing
Venous blood sampling is the gold standard for lead exposure assessment 1
- More reliable than capillary samples
- Required to confirm elevated capillary results
- Should be analyzed by laboratories that can achieve routine performance of ±2 μg/dL for blood lead analysis 1
Capillary blood sampling (fingerstick)
Interpretation of Blood Lead Levels
For Adults 1:
| Blood Lead Level (μg/dL) | Recommended Action |
|---|---|
| < 5 | No action needed |
| 5-9 | Discuss health risks; Reduce exposure for pregnancy |
| 10-19 | Discuss health risks; Decrease exposure; Monitor BLL; Remove from exposure for pregnancy, certain medical conditions, long-term risks |
| 20-29 | Remove from exposure if repeat BLL in 4 weeks remains ≥ 20 μg/dL |
| 30-79 | Remove from exposure; Prompt medical evaluation and consultation advised for BLL > 40 μg/dL |
| ≥ 80 | Urgent medical evaluation and consultation; Chelation may be indicated if symptomatic and/or BLL ≥ 100 μg/dL |
For Children 1:
- CDC recommends intervention at BLLs ≥ 5 μg/dL
- No safe blood lead level has been identified in children 1
- More frequent monitoring is needed for children with BLLs approaching 10 μg/dL 1
Additional Testing Considerations
Supplementary Tests
Urine lead levels:
Plasma lead levels:
Follow-up Testing Protocol
- For adults with BLLs between 10-19 μg/dL: quarterly blood lead measurements 1
- For adults with sustained BLLs < 10 μg/dL: semiannual blood lead measurements 1
- For children with elevated levels: follow-up testing schedule should be based on initial BLL, age, and exposure risk factors 1
Common Pitfalls and Caveats
Laboratory variability: Federal regulations allow laboratories to operate with a total allowable error of ±4 μg/dL or ±10%, whichever is greater 1. Choose laboratories with demonstrated precision of ±2 μg/dL.
Capillary sample contamination: False elevations can occur due to lead dust on skin. Proper cleaning protocols must be followed 1.
Inadequate follow-up: Studies show many children with elevated levels (36.3%) do not receive appropriate follow-up testing 4.
Missing ongoing exposure: A single BLL does not reflect cumulative body burden or predict long-term effects 1.
Limited screening coverage: Most children living in high-risk communities are not adequately tested for lead poisoning despite recommendations 5.
Remember that primary management of lead poisoning is source identification and removal from exposure, with laboratory testing serving as a critical tool for diagnosis and monitoring.